CLOVER BIOPHARMACEUTICALS, LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.345 HKD | -.--% |
|
+4.55% | -44.35% |
| Apr. 12 | Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding | CI |
| Apr. 08 | Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial | MT |
Chart calendar Clover Biopharmaceuticals, Ltd.
2b2fd936ae353de074a79c1747.ObI8NLzL_Oj11lUvi_vsd8ACNBVKq25_eWEy29RQHEE.X_haa8yCzNvHoQBV4bSrJoNMd2Ap3SU5HCxTq6MWKi9c-FdkyYa9sLGzGA~b8d66ca26ad793935c5f84d578378ff7
Upcoming events on Clover Biopharmaceuticals, Ltd.
Past events on Clover Biopharmaceuticals, Ltd.
| 2024-03-25 | Q4 2023 Earnings Release |
| 2023-08-22 | Q2 2023 Earnings Release |
| 2023-05-29 10:00 pm | Annual General Meeting |
| 2023-03-28 07:45 pm | Q4 2022 Earnings Release |
| 2022-08-23 | Interim 2022 Earnings Release |
| 2022-06-13 | Credit Suisse Asia Healthcare Corporate Day |
| 2022-05-26 10:00 pm | Annual General Meeting |
| 2022-05-23 | Morgan Stanley Virtual China Summit |
| 2022-04-18 03:15 pm | World Vaccine Congress Washington Conference |
| 2022-04-10 | Needham Virtual Healthcare Conference |
| 2022-03-29 07:16 am | FY 2021 Earnings Release |
| 2022-03-21 | Morgan Stanley's Virtual Hong Kong Summit |
| 2022-03-20 | Credit Suisse Asian Investment Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 |
|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 0,00 | 0,00 190 - | 0,00 0,00 - |
|
EBITDA Million CNY | Released Forecast Spread | 0,00 | -2 125 -2 098 -1.28% | -1 845 -2 144 13.95% |
|
EBIT Million CNY | Released Forecast Spread | 0,00 | -2 134 -2 120 -0.63% | -1 876 -2 117 11.39% |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
|
Net income Million CNY | Released Forecast Spread | -913 | -6 016 0,00 - | -2 452 -2 151 -13.99% |
|
EPS CNY | Released Forecast Spread | -18,3 | -13,0 -28,8 54.73% | -2,22 -1,66 -33.73% |
| Announcement Date | 25/10/21 | 29/03/22 | 28/03/23 |
Quarterly results
| Fiscal Period | December | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 |
|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,26 678 -99.96% |
|
EBIT Million CNY | Released Forecast Spread | -759 -1 091 30.43% | -1 065 -1 091 2.34% | -1 081 -770 -40.31% | -795 -1 077 26.17% | -518 -188 -174.56% |
| Announcement Date | - | 29/03/22 | 23/08/22 | 28/03/23 | 22/08/23 |
More events
Past sector events for Clover Biopharmaceuticals, Ltd.
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 2197 Stock
- Calendar Clover Biopharmaceuticals, Ltd.
